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The number of mRNAs and proteins that can be produced from a single gene is known to be increased by the number of start sites and by
multiple splicing of products. A few genes have been found to generate extraordinarily large numbers of splicing isoforms. In the human, the
largest number, nearly 2000 mRNA isoforms, has been reported for the neurexin 3α gene. However, the biological significance of alternative
splicing often remains unclear because many alternative transcripts contain early translational stops and are thought to be rapidly degraded. We
demonstrate here that human basonuclin 2 (bn2; approved gene symbol BNC2) transcripts are initiated from six promoters, are alternatively
spliced at multiple positions, and are polyadenylated at four sites. Characterization of nearly 100 bn2 mRNA isoforms suggests that each promoter,
splice site, and poly(A) addition site is used independently. The bn2 gene has therefore the potential to generate up to 90,000 mRNA isoforms
encoding more than 2000 different proteins. Because alternative exons affect the position of the first methionine codon, the length of the coding
region, and the position of the translational stop, the encoded proteins range in size from 43 to 1211 amino acids and some bear no sequence
similarity to others. PCR analysis and transient expression in HeLa cells show that the major bn2 mRNA isoforms are stable and are translated into
equally stable proteins, even when the mRNA bears an early translational stop.
© 2006 Elsevier Inc. All rights reserved.Keywords: Basonuclin 2; Alternative splicing; Zinc fingersThe recently discovered basonuclin 2 (bn2) possesses three
separated pairs of zinc fingers and a nuclear localization signal
(NLS) [1,2]. It is the paralog of basonuclin 1 (bn1), a protein that
also contains three separated pairs of zinc fingers [3]. The
deduced amino acid sequences of bn1 and bn2 of the mouse are
about 44% identical [2]. Bn2 is one of the most evolutionarily
conserved zinc finger proteins [2,4]. Bn2 is present in virtually
every cell type and its function is likely to be related to mRNA
splicing or other forms of mRNA processing [4].
The gene for bn2 (approved gene symbol BNC2) was initially
thought to contain six exons spread over more than 430 kb of
DNA on human chromosome 9 [1,2]. While we were
characterizing the 5′ end of the human bn2 gene by rapid ampli-
fication of cDNA ends (5′ RACE), we discovered that the gene
possessed in fact six promoters and at least 23 exons, all of which☆ Sequence data from this article have been deposited with the GenBank Data
Library under Accession Nos. DQ884933–DQ884948.
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doi:10.1016/j.ygeno.2006.07.006were alternative.We describe here a large number of bn2 mRNA
splicing isoforms and the consequences of alternative splicing
on the zinc finger pattern of the protein. We provide arguments
that support the biological relevance of many of the splicing
events characteristic of the human bn2 mRNA. We also demon-
strate that the bn1 mRNA is not subject to alternative splicing.
Results
Human bn2 transcripts are initiated from one major and five
minor promoters
We have previously reported that the human bn2 gene is
located at 9p22 and contains six exons (numbered 1 to 6) encoding
a 1032-residue protein. The first four exons are short (103–
236 bp) and do not encode the zinc fingers. The fifth exon, which
is 1970 bp in length, contains the putative NLS, the first three zinc
fingers, and a part of the fourth zinc finger. The sixth exon
contains the remaining part of the fourth finger, the fifth and sixth
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simultaneously, Romano et al. [1] also reported the structure of the
human bn2 gene, which they have inferred from that of a cloned
mouse cDNA. Their gene, which encodes a 1021-residue protein,
differs from ours in its length (300 kb instead of 435 kb) and its
first two exons, but is identical in its last four exons. Examination
of the Romano sequence (GenBank Accession No. AY438376)
showed that the cDNAwas likely to be incomplete since it began
within exon 2a (Fig. 1), a coding exon that we had previously
identified as alternatively spliced in the mouse (see Fig. 4 in [2]).
To determine unambiguously the transcription start site of the
human bn2 gene and the N-terminal sequence of the protein, we
decided to amplify the 5′ region of the mRNA by 5′ RACE. We
used mRNA prepared from testis, a tissue that contains abundant
bn2 mRNA [2]. Initial attempts with conventional avian reverse
transcriptase failed, presumably because the enzyme was
arrested by secondary structures caused by the very high G+C
content of presumed exon 1 of human bn2 [2]. We therefore
decided to use a thermostable reverse transcriptase that allowed
reverse transcription to proceed at 65°C instead of 42°C.
Agarose gel electrophoresis of the 5′ RACE product resolved
five bands (Fig. 2A), but cloning and sequencing of the unfrac-
tionated mixture of 5′ RACE products revealed a total of nine
products, including an additional short product not detected in the
electrophoresis. These products resulted from the use of three
alternative initiation exons to which four internal exons were
alternatively spliced (Fig. 2A). The three initiation exons included
previously described exon 1 and two hitherto undisclosed exons
that we designated 1b and 2b (Supplementary Fig. 1). RT-PCR,
using a sense primer in exon 1, 1b, or 2b and an antisense primer in
exon 3, showed that products containing exon 1 could be visualized
by ethidium bromide staining after 30 cycles of amplification,
whereas those starting with either exon 1b or 2b required two
consecutive amplifications of 30 cycles each for visualization. We
concluded that exon 1 was a major human bn2 initiation exon,
whereas exons 1b and 2b were minor initiation exons.Fig. 1. Alignment of previously published human bn2 N-terminal sequences. V,
sequence reported by Vanhoutteghem and Djian [2]. R, sequence published by
Romano et al. [1]. M, sequence of major bn2 isoform. Vertical arrows show exon
boundaries. First methionines are framed. Numbers in parentheses indicate length of
the deduced proteins. The two previously published sequences differ in their N-
terminal regions but are otherwise identical. The sequence published by
Vanhoutteghem and Djian lacks exon 2a and was deduced from a minor splicing
isoform.That published byRomano et al. lacked part of exon2a, presumably because
it was deduced from an incomplete cDNA. The major form of human bn2 contains
the sequence encoded by exon 2a and consists of 1099 residues (see Fig. 4B).Examination of the GenBank human EST database revealed
three additional exons that were presumed to be initiation exons
because they were located at the beginning of ESTs prepared by
the oligo-capping method [5]. These exons were designated 2g,
2h, and 4a (Supplementary Fig. 1). Their presence in testis
mRNAwas demonstrated by nucleotide sequencing of RT-PCR
products obtained with an exon 2g, 2h, or 4a sense primer in
combination with an exon 5 antisense primer. The three exons
were confirmed to be initiation exons by the fact that no PCR
product was obtained using a sense primer in exon 1 and an
antisense primer in exon 2g, 2h, or 4a. The abundance of the
mRNAs containing exons 2g, 2h, and 4a was low since two
amplifications of 30 cycles each were required to generate
products that could be visualized by ethidium bromide staining.
In summary, transcription of the human bn2 gene was initia-
ted at one major upstream exon (exon 1) and five minor down-
stream exons (exons 1b, 2g, 2h, 2b and 4a), which were located
at positions +1, +3, +142, +155, +165, and +362 kb, respectively
(Fig. 2). The large distance separating each initiation exon
suggested that each possessed a separate promoter. In the mouse,
5′ RACE of testis RNA generated a single product beginning
with the mouse ortholog of human exon 1. We may conclude
that promoter 1 is shared between human and mouse, whereas
the five human minor promoters are not shared with the mouse.
The major human bn2 promoter is TATA-less and contains a
large CpG island
Ten clones derived from 5′RACE products containing exon 1
were sequenced. They all began at the same nucleotide position,
which should therefore be considered as the transcription start
site for promoter 1. Exon 1 contained 154 nucleotides; its last 3
nucleotides encoded a putative first methionine in frame with
exons 2–6 (Supplementary Fig. 1), as previously reported [2].
The 5′ flanking region of human exon 1 lacked a sequence
resembling a TATA box in its usual position 30 nucleotides 5′ of
the transcription start site, but contained two overlapping Sp1
sites, located within a G+C-rich region that extended between
positions −257 and +138. Two other G+C-rich regions were
found upstream and downstream of the initiation exon, res-
pectively (Supplementary Fig. 1). Transcription from TATA-less
promoters may require an activator protein such as Sp1 [6,7]. A
high concentration of CG dinucleotides is frequently found in
TATA-less promoters [8]. The bn1 promoter also lacks a TATA
box and possesses several Sp1 sites within a G+C-rich region [9].
The average G+C content of 80-bp blocks of the bn2 gene is
plotted in Fig. 2B. In most of the bn2 gene, the G+C content
varied between 20 and 60% and was overall about average for
mammalian DNA (40%). The G+C content reached conspicu-
ously higher values around positions +1, +44, +144, and
+390 kb. The most extensive of these G+C-rich regions was
located around +1 (positions −1148 to +712) and constituted a
CpG island [10,11], as identified using the EMBOSS-CPG-
PLOT program (Fig. 2C). The concentration of CpG’s in this
region exceeded 10 per 100 nucleotides. The CpG’s were
usually bounded by G or C, which are known to make them
resistant to de novo methylation [12].
Fig. 2. 5′ RACE, G+C content, and CpG island of human bn2 gene. (A) 5′ RACE of bn2 mRNA. Total human testis RNAwas purchased from Clontech. The 5′ end of
the bn2 mRNAwas amplified by 5′ RACE. First-strand synthesis was initiated from an antisense primer in exon 4, but the final 5′ RACE product resulted from nested
PCR amplification of the cDNA using an antisense primer in exon 3. Therefore all 5′ RACE products terminate in exon 3. Five bands were resolved by agarose gel
electrophoresis and staining with ethidium bromide. Arrows show the exon composition of each band, as determined by cloning and sequencing of the unfractionated
mixture of RACE products. Product 1, 3, whichwas not detected on the gel, was identified by cloning and sequencing. Heterogeneity of 5′RACEproducts resulted from
the use of three alternative initiation exons (1, 1b, and 2b) and four alternatively spliced internal exons (1cS, 2, 2a, and 2e). (B) Percentage of G+C of bn2 gene. The G+
C content for each 80-bp block of the sequence is given. The whole human bn2 gene is shown on the abscissa. (C) CpG island. It was defined as a region whose G+C
content and observed/expected CG dinucleotide ratio were in excess of 60% and 0.6, respectively, over a continuous stretch of more than 500 bp. The human bn2 gene
(461 kb) contains a single CpG island located immediately upstream of exon 1. Positions of the six initiation exons and of exon 6 are indicated with vertical arrows.
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TATA-less. All of them lacked Sp1 sites and a CpG island. Exons
1b, 2g, and 4a were noncoding. Exon 2b terminated with a
putative ATG codon in frame with exons 2–6. Exon 2h was
partially coding (Supplementary Fig. 1).
The human bn2 gene contains 23 exons, all of which are
alternative
We had previously described alternative exons 5a and 5b,
both located between exons 5 and 6 [2]. As shown in Fig. 2A,5′ RACE had disclosed, in addition to 3 initiation exons, 3
previously unknown alternative internal exons (1c, 2a, 2e). In
view of these results, we searched GenBank for more human
bn2 exons and identified 4 additional alternative internal
exons (1d, 2f, 5c, 5d) and 1 alternative termination exon (3a).
RT-PCR analysis and nucleotide sequencing showed that all
these exons were present in testis bn2 mRNA. RT-PCR also
revealed further complexity resulting from: (1) the existence of
additional alternative exons 2c and 2i; (2) the presence of
multiple splice sites in exons 1c, 5c, and 6; (3) alternative
retention of the small intron separating exons 2h and 2a. In
47A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–58summary, we identified in the human bn2 gene a total of 6
initiation exons (Supplementary Fig. 1), 15 internal exons, and
2 termination exons (Supplementary Fig. 2). As none of the 23
exons identified was present in all bn2 mRNA isoforms, all 23
exons should be considered as alternative. The list of the
human bn2 exons is given in Supplementary Table 1.
The 23 exons were spread over four bacterial artificial
chromosomes derived from human chromosome 9 (Fig. 3A) and
could be found on contig NT_008413, where they spanned
461 kb of DNA (Fig. 3B). Alignment of the bn1 exons with
those of bn2 showed that all 5 exons of bn1 possessed a paralog
in bn2 (Fig. 3C).
Three classes of exons defined by the way in which their
alternative splicing affects the structure of the protein
As shown in Fig. 3D, bn2 exons could be divided into three
classes, according to the way in which their inclusion affected
the structure of the encoded proteins. The first class (“the
upstream exons”) caused variations in the N-terminal sequenceFig. 3. Structure of human bn2 gene. (A) Overlapping bacterial artificial chromosome
of the BACs are indicated. (B) Map of the human bn2 gene. Exons are represented by
in [2] are numbered 1, 2, 3, 4, 5, and 6. Additional exons are designated by n
(C) Correspondence of paralogous exons of bn1 and bn2. Paralogous sequences are
downstream exons with respect to regions of interest of the bn2 protein.of the protein without affecting the zinc fingers. It was composed
of the 16 exons located upstream of exon 5 (exons 1, 1d, 1b, 1c,
2, 2f, 2h, 2a, 2g, 2b, 2i, 2c, 2e, 3, 4, and 4a). The second class
(“the downstream exons”) affected the last three zinc fingers (see
below) and consisted of exons 5, 5c, 5d, 5a, 5b, and 6. The third
class consisted of exon 3a alone. Because exon 3a is a termi-
nation exon located upstream of zinc finger-encoding exons 5
and 6, its inclusion results in short N-terminal peptides lacking
all the zinc fingers and the NLS.
Major and minor upstream exons defined by their relative
abundance in bn2 mRNA
By combining the results of RT-PCR analysis, 5′ RACE, and
inspection of the human EST database at GenBank, we
identified 23 combinations of upstream exons, which, when
spliced to exons 5 and 6, encoded 16 proteins varying in size
from 864 to 1150 amino acids (Figs. 4A and B).
To determine the relative frequency at which different up-
stream exons were included in the mRNA, we prepared totals (BACs) covering the whole human bn2 gene; the GenBank accession numbers
vertical lines or black boxes, depending on their size. Exons previously described
umerals followed by a small letter. Arrows indicate transcription start sites.
shaded. (D) Positions of sequences encoded by upstream exons, exon 3a, and
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sense primer in exon 1 and an antisense primer in exon 3. After
30 cycles of amplification, three bands were visualized by ethi-
dium bromide staining in both testis and kidney. Cloning and
sequencing showed that the most intense band corresponded to
the combination 1, 2, 2a, 3; the second most intense band to the
combination 1, 2a, 3; and the least intense band to several
products that included exons 1, 2, 2a, and 3 in combination with
exon 1c short (1cS), 1d, 2c, or 2e (Fig. 4C, left). None of the
other upstream exons were detected, presumably because of
their low abundance in transcripts.
We then carried out PCRs with a sense primer in each of the
upstream exons and an antisense primer in either exon 3 or exon
5. All products generated with sense primers in exon 1, 2, 2a, 3,
or 4 could be visualized by ethidium bromide staining after a
single round of 30 cycles of amplification, whereas those
generated with primers in the other upstream exons required two
rounds of PCR amplification (examples are shown in the right
three gels of Fig. 4C). Exons 1, 2, 2a, 3, and 4 should therefore be
considered as the major upstream exons, whereas all other
upstream exons (1b–d, 2b–i, and 4a) were minor exons. It is
worth noting that the minor exons were always correctly spliced
to the major exons in the RT-PCR products examined and are
therefore genuine exons.
It was difficult from these experiments to determine the total
proportion of bn2 transcripts containing minor exons. Since the
GenBank human EST database contains a large number of bn2
sequences, the frequency at which minor bn2 exons occur in the
database should provide a reliable estimate of their relative
abundance in mRNA. Results are shown in Supplementary
Table 2. It can be seen that 24 ESTs contained upstream exons.
The combinations 1, 2, 2a, and 3 and 1, 2a, and 3 were present in
10 (42%) and 4 ESTs (17%), respectively. The combination 1, 3
was found at a lower frequency (2/24 or 8%). Eight minor
upstream exons, each confined to a single EST, were found in the
database: 1d, 1cS, 1c long (1cL), 2f, 2h, 2g, 2b, and 4a. There-
fore, the total frequency of minor exons reached 33% (8/24)
of all informative ESTs.
All major human upstream exons are shared with the mouse
All major human upstream exons (1, 2, 2a, 3, and 4) had a
mouse ortholog that could be clearly identified by a search of the
mouse EST database and by RT-PCR analysis of mouse testisFig. 4. Alternative splicing of upstream exons. (A) Schematic representation of hum
numerals as in Fig. 3B. Coding regions are solid. Asterisks indicate the presence of al
exon 6. A single bn2 isoform uses the distal splice site of exon 1c and therefore con
possess exon 1c short (1cS). Alternative retention of the small intron separating exons
in exons 3a and 6. (B) Isoforms resulting from alternative splicing of upstream exon
spliced directly to exon 6, although various combinations of exons 5c, 5d, 5a, and 5b
isoforms are identified by a thick and a thin arrow, respectively. Regions of interest of
serine stripe). The number of residues of each bn2 isoform is shown to the right. Alter
regions but retaining all six zinc fingers and the NLS. (C) Left shows an RT-PCR analy
initiated from an antisense primer in exon 6 was submitted to 30 cycles of amplificati
on an agarose gel and visualized with ethidium bromide. Nucleotide sequencing confi
2, 2a, and 3, while the second most abundant consisted of exons 1, 2a, and 3. Some
Faint nonspecific bands were visible in testis. The three other gels show RT-PCR an
rounds of amplification of 30 cycles each.RNA. However, these exons varied in their level of conservation
between the two species.
Exon 1 was shorter in the mouse than in the human, but the
105 nucleotides that were shared between the two species
showed nearly 91% identity. This high level of conservation
extending largely into the noncoding region upstream of the first
ATG codon showed that exon 1must have important functions in
addition to encoding the major first methionine (Supplementary
Fig. 1). These functions would presumably operate at the gene or
mRNA level. Although exon 2 was entirely coding, its level of
conservation was relatively low: the amino acid sequence
encoded by exon 2 showed 68% identity between the human and
the mouse; the corresponding value for the whole protein is 97%
[2]. Exons 2a, 3, and 4were all highly conserved between human
and mouse (Supplementary Table 3).
The genomic sequences orthologous to human exons 1 and 2
could not be found in vertebrates other than mammals,
presumably because these sequences were too divergent from
those of mammals to be identified. Exons 1 and 2 are res-
pectively located about 150 and 10 kb upstream of exon 2a in the
human (Fig. 3B). We could not detect any identity to these exons
within the 200 kb of DNA located upstream of chicken exon 2a
on chromosome Z, although over 98% of this sequence has been
determined. Exons 2a, 3, and 4 were clearly identified in the
chicken, the frog, and the zebrafish. Among these species, the
amino acid sequence encoded by exon 2a was significantly less
conserved than that encoded by exons 3 and 4 (Supplementary
Table 3).
The frequency of inclusion of the major bn2 upstream
coding exons appeared to be correlated with their level of
conservation: exon 2 was included in about 2/3 of the mRNA
isoforms, exon 2a in over 90%, exons 3 and 4 always (except for
isoforms terminating with exon 3a and the rare isoforms
beginning with exon 4a).
The presence of exons 2a, 3, and 4 in species as distant as the
human and the zebrafish shows that the protein sequences
encoded by these exons, especially exons 3 and 4, are likely to
serve important functions. In contrast, the absence of an
ortholog of exon 2 beyond the mammals means that the encoded
sequence has either no function or a function specific to the
mammals (Supplementary Table 3).
We had previously shown that the bn1 and bn2 genes shared
a common origin [2]. Exon 1 of bn1 is likely to be a paralog of
exon 1 of bn2. Although these exons bear no appreciablean bn2 gene. Exons are represented by boxes; they are designated by Arabic
ternative splice donor sites in exons 1c and 5c and of alternative acceptor sites in
tains the long isoform of exon 1c (1cL); all other exon 1c-containing isoforms
2h and 2a is shown by dotted lines. a(n) indicates the polyadenylation sites found
s and identified by RT-PCR are illustrated. All isoforms shown contain exon 5
could also be included (see Fig. 6). The most and second most abundant mRNA
putative proteins encoded by each alternatively spliced mRNA are assigned (ss:
native splicing of upstream exons results in proteins differing in their N-terminal
sis of the 5′ region of the bn2 RNA, in which the product of reverse transcription
on in the presence of primers in exons 1 and 3. The PCR products were resolved
rmed that in both testis and kidney the most abundant product contained exons 1,
of the minor exons were detected in the faint band above the 1, 2, 2a, 3 product.
alyses of exons 4a, 2g, and 2h; products were visualized after two consecutive
49A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–58
Fig. 5. mRNA isoforms terminating in exon 3a. (A) Gene as in Fig. 4. (B) mRNA isoforms terminating in exon 3a. Transcripts encode small N-terminal peptides
lacking all zinc fingers and the NLS. (C) Products containing exon 3a are fairly abundant, since they can be visualized after 30 cycles of PCR amplification. Their
amount is about half that of transcripts terminating in exon 6, in both testis and kidney.
50 A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–58sequence similarity, they are both initiation exons surrounded
by a large CpG island. Exons 3 and 4 of bn2 are clearly
paralogous to exons 2 and 3 of bn1, respectively. In contrast,
neither exon 2 nor exon 2a of bn2 has a paralog in bn1 (Fig.
3C). These exons and particularly highly conserved exon 2a
might confer to bn2 functions that are not present in bn1.
Exon 2c is the only minor human upstream exon shared with
the mouse
In contrast to the major exons, which were all shared with the
mouse, only one of the orthologs of the human minor exons,
exon 2c, was found among the mouse bn2 ESTs present in
GenBank. However, the mouse genomic sequences orthologous
to some of the unshared human exons (1d, 2h, 2g, and 2b) were
extremely conserved between the two species and were sur-rounded by consensus splice sites in the mouse. Therefore it
cannot be excluded that exons 1d, 2h, 2g, and 2b also exist in
mouse transcripts. None of the mouse sequences orthologous to
the other unshared minor exons of the human could be identified
in the mouse genome. Exon 2e resulted from partial exonization
of an AluSx sequence (Supplementary Fig. 2) andmust therefore
be specific to the primates [13].
Exon 2c appeared to be an exception among minor exons
because it was found in a number of mammals, including the
mouse (NM_172870), the dog (DN345958), the pig
(BX675426), and the sheep (DY502119). Exon 2c was coding
in all species and the encoded protein sequence was highly
conserved, with 89% identity between the human and the
mouse. The amino acid sequence encoded by exon 2c might
therefore add important functionalities to the isoforms contain-
ing it.
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variability of the N-terminal region of human bn2
As shown in Fig. 4B, alternative splicing of upstream exons
caused large variations in the N-terminal region of human bn2,
which we have defined as the region encoded by exons located
upstream of zinc finger-encoding exons 5 and 6. The major
N-terminal region consisted of 223 residues, beginning with the
methionine encoded by exon 1, followed by the amino acid
sequences encoded by exons 2, 2a, 3, and 4 (Supplementary
Figs. 1 and 2). The only exons that would cause lengthening of
the N-terminal region were exon 1cS, which possessed a
methionine codon followed by 14 codons in frame with exon 2,
and exons 2c and 2e, both of which were entirely coding, with 28
and 37 in-frame codons, respectively. Because most of the other
upstream minor exons were entirely or partially noncoding and
located downstream of themethionine-providing initiation exon,
their inclusion would result in the first in-frame methionine
being located in exon 2h, 2a, 2b, 2e, 4, or 5, depending on the
exon combination. Shortened N-terminal regions could also
result from skipping of exons 2 and 2a. The N-terminal region
could vary from 0 to 284 residues (Fig. 4B).
Exon 3a results in short N-terminal peptides lacking all zinc
fingers and the NLS
Exon 3a was identified in seven human ESTs (Supplemen-
tary Table 2). As these ESTs invariably terminated with a poly
(A) not encoded in the genome, we concluded that exon 3a was
a termination exon. Exon 3a contained a sequence resembling a
poly(A) addition site 17 nucleotides upstream of the poly(A)
(Supplementary Fig. 2).
To obtain a measure of the abundance of exon 3a-containing
mRNA isoforms, we initiated first-strand synthesis with primers
in either exon 3a or exon 6, from either testis or kidney RNA.
The cDNAs were then subjected to 30 cycles of amplification
with primers in exons 1 and 3, and the products of the four RT-
PCRs were visualized by ethidium bromide staining. Results are
shown in Fig. 5. Each of the four RT-PCRs produced the same
three bands, which corresponded to the usual combinations of
upstream exons detected after 30 cycles of amplification (see
Fig. 4C). We may conclude that splicing of exon 3a occurs in
both kidney and testis and does not affect alternative splicing of
upstream exons. Quantitation of the bands using a digital
scanner showed that products initiating from exon 3a were
about half as abundant as those initiating from exon 6. This ratio
was similar in testis and kidney. Transcripts terminating in exon
3a therefore represented a substantial fraction of the bn2
transcripts found in testis and kidney. The abundance of exon 3a
contrasted with that of the minor upstream exons, none of which
produced a detectable band after a single round of 30 cycles of
PCR amplification.
The mRNA isoforms containing exon 3a encode short pep-
tides varying in size from 43 to 189 amino acids. The only region
shared by all peptides consisted of the 34 amino acids encoded
by exon 3. The peptides lack all zinc fingers and the NLS. We
identified the genomic mouse sequence corresponding to humanexon 3a, and we did find two mouse ESTs containing this
sequence (GenBank Accession No.CK345374 and AW553771).
We conclude that exon 3a is also likely to exist in the mouse.
Downstream alternative exons occur with high frequency in
bn2 mRNA and one of them shows tissue-specific splicing
It was clear that exons 5 and 6, which encode all six zinc
fingers and the NLS, were the major downstream exons, since
they were included in all the transcripts that did not terminate
with exon 3a. In contrast to exons 5 and 6, the other four
downstream exons (5c, 5d, 5a, 5b) were included in transcripts
with variable frequency (Figs. 6A and 6B). Asmentioned earlier,
exon 5c could use either of two splice donor sites and therefore
existed as 2 isoforms that we designated 5c short (5cS) and 5c
long (5cL). There also existed 2 isoforms of exon 6 (6S and 6L),
which differed by two codons through use of alternative splice
acceptor sites. Examination of the EST database (Supplementary
Table 2) and RT-PCR analyses revealed 9 bn2 mRNA isoforms
resulting from alternative splicing of exons 5c, 5d, 5a, and 5b
(Figs. 6A and 6B). RT-PCR of testis mRNA with first-strand
synthesis initiated within exons 5a–5d, followed by PCR ampli-
fication with primers in exons 1 and 5, showed the existence of
24 additional bn2 mRNA isoforms in which exons 5c, 5d, 5a,
and 5b were associated with various combinations of upstream
exons. The major upstream exon combinations were here again
1, 2, 2a, 3, 4 and 1, 2a, 3, 4, but minor upstream exons were also
found (Fig. 6C, upper left). This result strongly suggested that
splicing of the bn2 pre-mRNA proceeded in a purely combi-
natorial fashion since exons 5c, 5d, 5a, and 5b could each be
associated with many combinations of upstream exons.
To determine the abundance of products containing exons
5c, 5d, 5a, and 5b relative to that of products in which exon 5
was spliced directly to exon 6, we carried out RT-PCR with
primers in exons 5 and 6. Testis and kidney were both exa-
mined. Results are shown in the upper right of Fig. 6C. A strong
band corresponding to the exon 5–6 product was clearly visible
in both tissues. A smear extending above the 5–6 product was
detected in testis. A band, which extended to sizes smaller than
that of testis, was observed above the 5–6 product of kidney.
Cloning and sequencing showed that the smear of testis con-
tained exons 5 and 6 associated with various combinations of
exons 5b, 5cS, 5cL, and 5d, whereas that of kidney contained
exons 5 and 6 combined with exon 5b alone. We may conclude
that neither exon 5c nor exon 5d was included in kidney
transcripts. Exon 5a was not detected in either testis or kidney,
possibly because its relatively large size hindered its amplifica-
tion. Scanning of the bands showed that the total amount of the
testicular isoforms containing exon 5b, 5c, or 5d equaled 1.2
times the amount of the isoform in which exon 5 was spliced
directly to exon 6. In kidney, the amount of the 5, 5b, 6 isoform
was 0.4 that of the 5–6 isoform. A search of the GenBank
database retrieved 14 human bn2 mRNA and EST sequences
that included downstream exons. In 9 of these sequences (64%),
exon 5 was spliced directly to exon 6, while the remaining 5
(36%) contained various combinations of exons 5c, 5d, 5a, and
5b associated with exons 5 and 6 (Supplementary Table 2).
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isoforms containing exons 5c, 5d, 5a, and 5b was roughly
comparable to that of the 5–6 isoform.
To confirm that exon 5c was missing from kidney transcripts,
we subjected kidney RNA to RT-PCR specific for either exon 5bor exon 5c. Testis mRNA was examined in parallel. In testis,
PCR with a primer in 5b produced two bands, which
corresponded to inclusion of 5b either alone or combined with
5c. In contrast, a single band corresponding to 5b alone was
detected in kidney (Fig. 6C, lower left). RT-PCRwith a primer in
53A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–58exon 5c confirmed the presence of exon 5c in testis RNA and its
absence from kidney RNA (Fig. 6C, lower right). Splicing of
exon 5c was tissue-specific, since it was observed in testis but
not in kidney. This contrasted with splicing of exon 5b, which
was observed in both tissues. We cannot exclude that a small
amount of exon 5c-containing bn2 mRNA exists in kidney.
Downstream exons affect the zinc finger pattern
The consequence of the inclusion of exons 5c, 5d, 5a, and 5b
on the bn2 coding region is illustrated in Fig. 7A. Exons 5a, 5b,
and 5d should be considered separately from exon 5c. Because
exons 5a, 5b, and 5d all possessed a stop codon in frame with
exon 5, their presence in any combination resulted in proteins
truncated within zinc finger 4. Such proteins contained the first
pair of zinc fingers, the NLS, and the third zinc finger, all
encoded by exon 5, but lacked the last three fingers and the
serine stripe encoded by exon 6.
The two isoforms of exon 5c resulted from the presence of
alternative splice donor sites located 4 nucleotides apart
(Supplementary Fig. 2). Both exon 5c isoforms encoded 2
histidines separated by 4 residues toward their 3′ end. Therefore
the splicing to exon 5 of either exon 5c isoform reconstituted a
zinc finger domain, but with a sequence between the second
cysteine and the first histidine, which, with 25 residues, was
much longer than the original 12 residues of finger 4 (Fig. 7A).
It will have to be determined whether the 25-residue CH spacing
of altered finger 4 allows formation of a zinc finger.
Although the two isoforms of exon 5c had the same effect on
finger 4, they differed in their effects on fingers 5 and 6. The
short form of exon 5c consisted of 62 nucleotides. Since 62 is
not a multiple of 3, inclusion of exon 5c short-shifted the
reading frame of exon 6, introduced a stop codon at the begin-
ning of exon 6, and suppressed fingers 5 and 6. In contrast, the
66 nucleotides of the long isoform of exon 5c did not affect the
coding region of exon 6 and resulted in proteins retaining
fingers 5 and 6 (Fig. 7A).
Exons 5b and 5c are evolutionarily conserved
Exons 5b and 5c were found in mouse testis RNA by
RT-PCR. Their nucleotide sequence was very conserved
between the human and the mouse, with identities of 100 and
95%, respectively. Exon 5b was also found in bn2 ESTs derived
from the pig (Accession No. BF191964) and the chickenFig. 6. Alternative splicing of downstream exons. (A) Gene as in Fig. 4. (B) Isoform
alternative splice sites in exons 5c and 6 (see legend to Fig. 4). Unless otherwise indic
combination 1, 2, 2a, 3, 4; a large number of additional isoforms containing other com
Exons 5c, 5d, 5a, and 5b can occur in various combinations, most of which encode C
NLS, but lacking the last three fingers encoded by exon 6. Inclusion of exon 5cS alter
in exon 6, thus suppressing zinc fingers 5 and 6 and possibly zinc finger 4. Exon 5c
proteins would contain either five or six fingers, depending on whether altered finger 4
each of the alternative downstream exons and subsequently amplified by 30 cycles wi
either exon 5b or exon 5c were more abundant than those containing either exon 5
containing exons 5b and 5c was comparable to that of isoforms in which exon 5 was s
(Lower left) Amplification with a primer in exon 5b showed the presence of exon 5b
exon 5b were detected in testis alone. (Lower right) Amplification with a primer in(Accession No. CV855344). Human exon 5b showed 99 and
91% identity with its pig and chicken orthologs, respectively
(Fig. 7B). The conservation of exons 5b and 5c suggests that
they possess important functions: presumably suppression of
the last three fingers for exon 5b and alteration of finger 4 for
exon 5c.
In contrast, neither exon 5a nor exon 5d could be found in
nonhuman ESTs. Part of the sequence corresponding to exon 5a
was found in the mouse genome, but the rest of exon 5a could
not be found, neither was the entire exon 5d. We conclude that
exons 5a and 5d are probably absent from the mouse.
The human bn2 transcript is polyadenylated at three
alternative sites in exon 6
We had previously reported that the size of the human bn2
transcript was about 6 kb. Reexamination of the Northern blot
used in this analysis showed additional bands of weaker
intensity at about 4 and 13 kb (see Fig. 5 in [2]). Such large
differences in size could not be ascribed to alternative splicing
and were more likely to result from the use of different poly
(A) addition sites. The sum of the 5′ untranslated and coding
regions of the main human bn2 mRNA isoform (1, 2, 2a, 3–6)
is 3448 nucleotides. To produce three transcripts with sizes of
4, 6, and 13 kb, the three poly(A) addition sites would have to
be located about 550, 2500, and 9500 nucleotides downstream
of the translation stop, respectively.
We searched the human EST GenBank database with the
putative 13 kb bn2 mRNA sequence, which included the 3448
nucleotides of 5′ untranslated and coding sequences followed by
the 9.5 kb of genomic sequence located 3′ of the translation stop
on BAC AL449983 (Fig. 3A). This search retrieved 137 ESTs
spread over the whole length of the putative mRNA sequence.
Three poly(A) addition sites were identified, based on the fact
that several ESTs terminated at the same nucleotide position and
were thereafter followed by a poly(A) not encoded by the ge-
nome. These poly(A) addition sites resulted in mRNAs of 3892,
6035, and 12933 nt, respectively, when the exon combination 1,
2, 2a, 3–6 was assumed (Supplementary Fig. 2). A search with
genomic sequence located downstream of the 3′-most poly(A)
addition site failed to retrieve any EST.We conclude that there is
no poly(A) addition site located downstream of the 3′-most site
identified in exon 6.
The relative abundance of the 13-kb mRNAwas greater than
anticipated from the weak intensity of the band detected bys resulting from alternative splicing of exons 5c, 5d, 5a, and 5b and from use of
ated, all bn2 isoforms contain exon 6L. All isoforms shown contain the upstream
binations of upstream exons have been detected, but are not shown (see Fig. 4).
-terminally truncated isoforms of bn2 retaining the first three zinc fingers and the
s the putative DNA binding region of finger 4 and leads to premature termination
L also alters zinc finger 4, but does not affect the last pair of fingers. Resulting
is functional. (C) RT-PCR analysis. The upper left shows products initiated from
th primers in exons 1 and 5. All four exons were detected. Transcripts containing
a or exon 5d. (Upper right) RT-PCR showing that the abundance of isoforms
pliced directly to exon 6. The products resulted from 30 cycles of amplification.
in both testis and kidney transcripts, but forms containing exon 5c in addition to
exon 5c confirmed the absence of exon 5c from kidney transcripts.
Fig. 7. Alteration of zinc finger 4 by exons 5c, 5d, 5a, and 5b and evolutionary conservation of exons 5b and 5c. (A) The sequence of zinc finger 4 in the major isoform
(5–6) and its alteration by inclusion of exon 5a, 5b, 5d, 5cS, or 5cL are shown. The cysteine and histidine residues are framed. Vertical arrows show exon junctions.
Total number of residues in each protein isoform is in parentheses. Insertion of exon 5a, 5b, or 5d disrupts the fourth zinc finger and interrupts the coding region very
shortly thereafter. Exon 5c encodes two histidines separated by 4 residues in frame with exon 5; its insertion recreates a zinc finger domain, but with a 25-residue
spacing between the second cysteine and the first histidine instead of the usual 12. Exon 5c can use two splice donor sites, the proximal of which (exon 5cS) leads to
premature termination in exon 6 and the distal of which (exon 5cL) maintains the coding region of exon 5 in frame with that of exon 6. (B) Conservation of exons 5b
and 5c in various species. Exon 5b is found in transcripts of the human (Hu), the mouse (Mo), the pig (Pi), and the chicken (Ch). Its nucleotide and translated (Tr)
sequences are extremely conserved. Exon 5c is also present in transcripts of several mammalian species, in which it is highly conserved.
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the two 3′-most poly(A) addition sites and must therefore have
originated from the longest mRNA. This is very likely an
underestimate, since some ESTs located in the upstream part of
the mRNA could also have originated from mRNAs poly-
adenylated at the downstream site. In summary, the human bn2
gene contains four poly(A) addition sites, one in exon 3a and
three in exon 6, and human bn2 mRNAs vary in size from 0.5 to
13 kb.
Total number and relative abundance of human bn2 isoforms
We have characterized nearly 100 bn2 mRNA isoforms, but
the number of isoforms is likely to be considerably greater since
alternatively spliced exons appear to associate in a combinator-
ial fashion. Isoforms beginning with exon 1 and terminatingwith exon 6 could contain any combination of 12 alternatively
spliced exons (1d, 1c, 2, 2f, 2a, 2i, 2c, 2e, 5c, 5d, 5a, and 5b).
Ten of these exons occur as a single variant and could be either
present or absent. Exons 1c and 5c each exist as two variants
thereby yielding three possibilities each: absence, short variant,
long variant. Exon 6 is always present in the 1–6 isoforms, but
exists as two isoforms. Each isoform could use any of three poly
(A) addition sites. The total number of 1–6 isoforms therefore
reaches 210 ×32×2×3=55,296. Similar calculations would
yield for the isoforms beginning with exons 1b, 2g, 2b, and
4a values of 27,648 (29×32×2×3), 1152 (26 ×3×2×3), 1152
(26 ×3×2×3), and 148 (23 ×3×2×3), respectively. In mRNAs
starting with exon 2h, exon 2a could be absent, present as an
independent exon, or fused with exon 2h through intron reten-
tion. The number of isoforms beginning with exon 2h is there-
fore 3456 (3×26×3×2×3). Isoforms terminating with exon 3a
Fig. 8. Expression of bn2 isoforms in HeLa cells. The three bn2–myc isoforms
terminating in exon 6 were expressed for 24 h after transfection of HeLa cells;
that terminating in exon 3a was expressed for 4–6 h because its overexpression
for a longer time appeared to cause cell death. The expressed isoforms were
visualized by immunostaining with mAb against the c-myc tag and the DNAwas
counterstained with DAPI. The structure of each expressed protein isoform and
its encoding exons are illustrated. (A) Canonical form with six fingers. (B) Form
with an altered fourth finger. (C) C-terminally truncated form lacking the last
three fingers. (D) N-terminal peptide lacking all fingers and the NLS. The three
isoforms bearing the NLS are nuclear. The isoform terminating in exon 3a is
both nuclear and cytoplasmic. As there is no appreciable difference in the
intensity of the staining, the corresponding mRNAs appear to be translated with
similar efficiency into equally stable proteins.
55A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–58could also contain any combination of upstream exons and their
total number was computed at 616. The bn2 gene has therefore
the potential to generate a total of 89,468 mRNA isoforms. This
number should be considered as the theoretical upper limit of
the number of isoforms that can be generated from the 23 exons
that we have identified.
The number of protein isoforms potentially encoded by the
human bn2 gene is much lower than the number of mRNA
isoforms because many mRNA isoforms encode the same
protein. This number can be estimated from the number of first
methionines, termination codons, and coding exons that could
be either skipped or inserted (Supplementary Figs. 1 and 2). The
total number of putative proteins is 2129.
Bn2 mRNA isoforms are translated into stable proteins in HeLa
cells
Although we have shown that a number of mRNA isoforms
were present in substantial amounts in various cell types, we
have not demonstrated whether these mRNAs were translated
into stable proteins. To determine this, we constructed several
plasmids, each of which encoded a different bn2 isoform fused
with a c-myc tag, so that the expression of each isoform could
be followed by immunofluorescence staining, using an anti-myc
antibody. These isoforms were expressed under the control of a
cytomegalovirus promoter in HeLa cells. Three of the expressed
isoforms contained a putative NLS; they were the canonical
form with six zinc fingers (exons 1, 2, 2a, and 3–6), a form
with a modified fourth finger (exons 1, 2, 2a, 3–5, 5cL, 6),
and a C-terminally truncated form containing only three fingers
(exons 1, 2, 2a, 3–5, 5b). The fourth expressed isoform was one
of the short N-terminal peptides, which lacked all fingers and the
NLS (exons 1, 2, 2a, 3, 3a).
All three isoforms bearing the NLS were present in the
nucleus (Figs. 8A–C). The isoform lacking an NLS was found
in both the cytoplasm and the nucleus (Fig. 8D). No difference
between the intensities of the immunological staining was
observed among the four isoforms. The four mRNA isoforms
were therefore translated with a similar efficiency into equally
stable proteins. We conclude that the endogenous protein iso-
forms are likely to exist in an amount proportional to that of
their encoding mRNA.
The human bn1 gene shows no evidence of alternative splicing
To determine whether the bn1 transcript was alternatively
spliced, we searched the human EST database of GenBank with
the sequence of the full-length 4.6-kb human bn1 mRNA that
was originally identified in cultured keratinocytes [3]. This
search retrieved 36 ESTs, none of which was alternatively
spliced. However, we identified a hitherto undisclosed poly(A)
addition site located at nucleotide position 3142 of the transcript.
Use of this alternative poly(A) addition site probably explains
why a shorter mRNA of about 3.2 kb was previously detected in
human testis, in addition to the usual 4.6-kb mRNA [14,2]. The
poly(A) addition site at nucleotide 3142 must be specifically
used in testis, since it is not used in keratinocytes, the only other
56 A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–58cell type containing bn1 [3]. The 4.6- and 3.2-kb mRNAs both
encode the same protein.
Discussion
Through a combination of multiple promoters, alternatively
spliced exons, multiple splice sites, intron retention, and
multiple poly(A) addition sites, the human bn2 gene has the
potential to generate nearly 90,000 mRNA isoforms encoding
over 2000 protein isoforms. To our knowledge this is the largest
number of mRNA isoforms that can be produced from any
known gene. Since it is likely that some exons have escaped
detection, the number of isoforms is likely to be much greater. In
contrast, the human bn1 gene generates only 2 mRNA isoforms,
each encoding the same protein. It appears that a diverse set of
mechanisms has been targeted to the bn2 gene to increase the
multiplicity of its products. No such mechanisms have been
targeted to the paralogous bn1 gene.
The only gene that compares with the human bn2 gene in
number of different transcripts is the Drosophila DSCAM gene,
with a potential for over 38,000 mRNA isoforms. However the
DSCAM gene largely exceeds bn2 in the number of potential
proteins, since each DSCAM mRNA isoform encodes a
different protein [15]. Remarkable but less extensive examples
in mammals are the slo and neurexin genes, which can generate
500 and 2000 mRNA isoforms, respectively [16–18]. The slo
gene (approved gene symbol KCNMA1) encodes a calcium-
activated potassium channel and the neurexin genes encode
cell-surface receptors. In these two examples, all protein
isoforms are thought to carry out the same basic function and
to differ by subtle physiological properties, such as differences
in Ca2+ sensitivity for the slo protein or alterations in ligand
specificity for neurexins. Alternative splicing of the bn2
transcript has much more drastic consequences, since it can
produce a family of peptides lacking all zinc fingers and the NLS
and that are therefore likely to possess functions unrelated to
those of the longer bn2 isoforms. It is remarkable that some of
these peptides share no sequence with some of the longer bn2
isoforms.
It is generally thought that alternative-splicing events
conserved between the human and the mouse are likely to be
of primary biological importance [19]. Because exons that are
included only in minor splice isoforms are mostly not conserved
between the human and the mouse [20], they are thought to be
functionally irrelevant [21]. It is clear that most alternative
upstream bn2 exons fall into this category, since they are not
conserved between the human and the mouse. It is therefore
doubtful whether most of the variations of the bn2 N-terminal
region resulting from inclusion of alternative upstream exons are
biologically significant. In contrast, exon 3a and the alternative
downstream exons, whose inclusion leads to alterations of the
zinc finger pattern or to generation of small N-terminal peptides,
are conserved in evolution and occur with high frequency. This
suggests that the protein isoforms encoded by these variants
possess important biological functions.
Alternative splicing leading to transcripts containing early
translational stops has often been dismissed, because thecorresponding mRNAs are deemed unable to generate func-
tional products [22]. One of the main functions of alternative
splicing is thought to be the regulation of gene expression
through regulated unproductive splicing and translation. RT-
PCR analysis and transient expression of bn2 mRNA isoforms
containing early translational stops show that these transcripts
are stable and are translated into equally stable proteins (Fig. 8).
Therefore alternative splicing of the bn2 transcript does not
appear to be a means of regulating gene expression, but rather to
generate proteins whose functions presumably differ.
It has recently been discovered that the mouse bn2 gene was
part of the tyrosinase-related protein 1 (Tyrp1 or brown) deletion
complex. Within this complex, one locus, l4Rn3, causes early
embryonic death and contains the bn2 gene together with three
other genes and two large open reading frames. In view of the
fact that bn2 is extremely conserved and presumably highly
expressed in female germ cells [1], it would be expected that the
deletion of bn2 contributes to the lethal l4Rn3 phenotype. A
chromosomal inversion, white-based brown (Bw), also occurs
within the brown locus. Bw causes a loss of pigment at the base
of the hair, probably because it leads to premature death of
melanocytes at a late stage of each hair cycle. The inversion
places bn2 under the control of the Tyrp1 promoter, thereby
inducing overexpression of bn2 in melanocytes [23]. Melano-
cyte death is presumably due to the presence of an excessive
amount of bn2. Like the human transcript, the mouse bn2
transcript is subject to extensive alternative splicing and encodes
types of bn2 very similar to those found in the human. It will
have to be determined which of the bn2 isoforms causes embry-
onic death in the deletion phenotype and melanocyte death in the
inversion phenotype.
It has been estimated that there are about 2.5 alternatively
spliced forms per mRNA in both human and mouse [24]. This
number conceals the extreme disparities that exist between
genes such as bn1, which does not produce any alternatively
spliced forms, and bn2, which can produce tens of thousands.
Since the number of human genes has been estimated to be
20,000–38,000 [25,26], it takes a single gene like bn2 to bring
the average number of alternatively spliced forms per mRNA to
over 2.5. In studies of evolution, comparisons of DNA
sequences have received much more attention than the study
of the singular behavior of an individual gene. But the latter is
more instructive about the dynamism of the genome; and what
one gene can do, another may do. For this reason, more
attention should be paid to such events as illustrating genomic
mechanisms of evolutionary change.Materials and methods
Identification of bn2 exons of the human and other vertebrates
New human bn2 exons were identified by nucleotide sequencing of 5′
RACE and RT-PCR products generated with primers in previously described
exons [2]. These exons were then used in Blastn identity searches of the human
EST and nr databases at GenBank. This search disclosed ESTs and cDNAs in
which hitherto unknown exons were spliced to the exons used in the search.
Human exons were used in Blastn identity searches of the nonhuman ESTand nr
(restricted to cDNAs) databases. These searches identified mouse exons 2, 2a,
57A. Vanhoutteghem, P. Djian / Genomics 89 (2007) 44–582c, 3, 3a, 4, 5, 5c, 5b, and 6 and chicken exons 2a, 3, 4, and 5b. Because of the
relative scarcity of ESTs derived from Xenopus and zebrafish, most bn2 exons
from these species could not be found in EST databases. Their sequences were
identified on Xenopus genomic scaffold 162 and zebrafish contigs BX000462
and BX784393 (www.ensembl.org).
5′ RACE
The list of oligonucleotide primers used in 5′ RACE and RT-PCR is given in
Supplementary Table 4. Human RNA prepared from either testis or kidney was
purchased from Clontech. First-strand synthesis was initiated from 5 μg of testis
RNA, using a bn2-specific primer in exon 4 (4A) and the Thermoscript RT-PCR
system (Invitrogen Life Technologies). The 5′ RACE System for Rapid
Amplification of cDNA ends (Invitrogen Life Technologies) was used thereafter
to generate 5′ RACE products. After column purification of the cDNA, a dC-tail
(containing a SalI site for subsequent cloning) was added to the 3′ end of the
cDNA using terminal deoxynucleotide transferase. An aliquot of this reaction
was then amplified by PCR (95°C for 1 min, 55°C for 1 min, and 72°C for 1 min)
using primers that annealed to the dC-tail and to exon 3 (3A), respectively. To
generate sufficient product for visualization by ethidium bromide staining, a
second round of PCR amplification was carried out with the dC-tail primer and a
reverse nested exon 3 primer containing an EcoRI site (3AEco). 5′ RACE
products were cloned into pGEM-3Zf(−) (Promega), previously cut with SalI
and EcoRI.
RT-PCR
Human epidermal keratinocytes derived from foreskin of a newborn (strain
YF23) were propagated on mitomycin-treated 3T3-J2F cells as previously
described [27–30]. Total RNAwas prepared from human cultured keratinocytes
by scraping the cells into Tripure isolation reagent (Roche Applied Science).
RT-PCR was carried out using the SuperScript first-strand synthesis system
for RT-PCR (Invitrogen Life Technologies). First-strand synthesis was initiated
from 1 μg of total RNA prepared from either testis or kidney or 5 μg of RNA
prepared from cultured keratinocytes. Either oligo(dT) or an antisense bn2-
specific primer was used for initiation. The resulting cDNAs were then subjected
to 30 cycles of amplification (95°C for 1 min, 57°C for 1 min, and 72°C for
1 min) using various combinations of exon-specific sense and antisense primers.
Products containing rare exons were amplified by two consecutive rounds of 30
cycles each. Bands on agarose gels were quantitated with an Agfa digital light-
sensing scanner and the FOTOLOOK v2.07 program; images were analyzed
with the IMAGEJ program (NIH Image for PC).
Cycle sequencing of 5′ RACE and RT-PCR products was performed on a
Perkin–Elmer GeneAmp PCR System 2400 in the presence of fluorescent
dideoxynucleotides. Thermocycling conditions were 30 cycles at 96°C for 30 s,
50°C for 15 s, and 60°C for 4 min. Electrophoresis and detection of fluorescent
peaks were carried out on an automatic sequencer (ABI Prism 310 genetic
analyzer). The sequences were determined using the SeqEd v1.0.3 software.
Construction of plasmids
For construction of a plasmid expressing the bn2 isoform encoded by exons
1, 2, 2a, 3, 4, 5, and 6, a cDNAwas generated by RT-PCR. First-strand synthesis
was initiated from 1 μg of testis RNAwith oligo(dT) and subsequently amplified
with primers 1SBam1 and 6APst, which contained a BamHI and a PstI site,
respectively (Supplementary Table 4). The PCR product was the result of 30
cycles of amplification (95°C for 30 s, 59°C for 1 min, and 68°C for 4 min) in
the presence of PfuTurbo DNA polymerase (Stratagene). After being digested
with BamHI and PstI, the PCR product was ligated to pGEM-3Zf(−) previously
cut with BamHI and PstI. One of the plasmids obtained (pHubn2) contained an
insert whose size corresponded to the exon combination 1, 2, 2a, 3, 4, 5, 6. The
presence of this exon combination was verified by sequencing the entire insert of
pHubn2. The insert of pHubn2 was then amplified with primers 1SBam2 and
6ASac. The PCR product was digested with BamHI and SacII and cloned into
the plasmid pcDNA 3.1/myc-His version B (Life Technologies), thus yielding
an expression plasmid (pcDNAHubn2) encoding bn2 fused to C-terminal c-myc
and poly(his) tags.To obtain plasmids that encoded isoforms resulting from the inclusion of
either exon 5b or exon 5cL, an RT-PCR was carried out in the presence of a
sense primer in exon 5 (5S) and an antisense primer in exon 6 (6A). The
resulting PCR products, which consisted of exons 5 and 6, either alone or
associated with various combinations of exons 5b, 5c, and 5d, were cloned by
A/T cloning into pGEM-T (Promega). Plasmids containing the combination of
either 5, 5b, 6 (p5b) or 5, 5cL, 6 (p5cL) were identified by sequencing. Part of
the insert of p5b was amplified using primer 5S and an exon 5b antisense
primer containing a SacII site (5bASac). The PCR product was digested with
BstEII and SacII and inserted into pcDNAHubn2, previously digested with the
same enzymes. The resulting expression plasmid, which contained the coding
region of exons 1, 2, 2a, 3, 4, 5, and 5b, was designated pcDNAHubn25b. To
generate a plasmid containing the coding region of exons 1, 2, 2a, 3, 4, 5, 5cL,
and 6, p5cL was digested with BstEII and HincII, thus releasing a 270-bp
exon 5cL-containing fragment. This fragment was inserted into pHubn2
previously cut with BstEII and HincII. The insert of the resulting plasmid
(pHubn25cL) was amplified with primers 1SBam2 and 6ASac. The PCR
product was digested with BamHI and SacII and cloned into pcDNA 3.1, thus
yielding plasmid pcDNAHubn25c.
For generation of a plasmid expressing the isoform encoded by exons 1, 2,
2a, 3, and 3a, an RT-PCRwas initiated with an antisense primer in exon 3a (3aA)
and subsequently amplified with primers 1SBam and 3aASac. The product
containing the coding region of exons 1, 2, 2a, 3, and 3a was resolved by agarose
gel electrophoresis, digested with BamHI and SacII, and ligated to pcDNA3.1.
The resulting expression plasmid was designated pcDNAHubn23a.
Transient expression of fusion proteins of bn2 isoforms
Cultures of HeLa cells were transfected with appropriate plasmids by
nucleoporation (2 μg per 106 cells) using the cell line Nucleofector Kit R
(Amaxa, Germany). Cultures were harvested after 24 h and fixed for
immunostaining.
Indirect immunofluorescent staining
All procedures were carried out at room temperature. Cells were inoculated
on glass coverslips, washed twice in phosphate-buffered saline solution (PBS),
fixed in 3.7% paraformaldehyde for 10 min, washed twice in PBS, and
permeabilized with 0.1% Triton X-100 for 5 min. Coverslips were incubated in
PBS containing 5% bovine serum albumin (BSA) for 15 min to block
nonspecific sites and then for 2 h in 5% BSA/PBS containing a monoclonal anti-
myc antibody (Life Technologies) diluted 1:1000. At the end of the incubation,
cells were washed three times for 5 min each with PBS containing 0.1% of the
nonionic detergent IGEPAL CA 630 (Sigma) and then incubated for 1 h in the
presence of 5% BSA/PBS containing a goat anti-mouse IgG linked to cyanin 3
(1:200 dilution; Jackson ImmunoResearch). At the end of the incubation,
coverslips were washed twice in PBS/IGEPAL for 5 min and once in water and
mounted onto slides in mounting medium containing DAPI (Vector Labora-
tories). Cells were photographed using a Nikon E600 fluorescence microscope
equipped with a Nikon digital camera.Acknowledgments
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